Page 1 | Search Results | Blood | American Society of Hematology

1-17 of 17

Sort by

Sort Order Select

Journal Articles

Bortezomib-Based Versus Standard of Care Reduced Intensity Conditioning Hematopoietic Stem Cell Transplantation: A Phase II Randomized Controlled Trial

John Koreth, MD, Haesook T. Kim, PhD, Paulina B Lange, Philippe Armand, MD PhD, Corey S. Cutler, MD MPH, Vincent T. Ho, MD, Brett Glotzbecker, MD, Rushdia Z. Yusuf, MBBS, MPH, Sarah Nikiforow, MD PhD, Bimalangshu R. Dey, MD PhD, Malgorzata McMasters, MD, Jerome Ritz, MD, Bruce R. Blazar, MD, Robert J. Soiffer, MD, Joseph H Antin, MD, Edwin P. Alyea, MD

Blood (2016) 128 (22): 508.

https://doi.org/10.1182/blood.V128.22.508.508

Published: 2016

Journal Articles

Efficacy, durability, and response predictors of low-dose interleukin-2 therapy for chronic graft-versus-host disease

John Koreth, Haesook T. Kim, Kyle T. Jones, Paulina B. Lange, Carol G. Reynolds, Marie J. Chammas, Katherine Dusenbury, Jennifer Whangbo, Sarah Nikiforow, Edwin P. Alyea, III, Philippe Armand, Corey S. Cutler, Vincent T. Ho, Yi-Bin Chen, David Avigan, Bruce R. Blazar, Joseph H. Antin, Jerome Ritz, Robert J. Soiffer

Blood (2016) 128 (1): 130–137.

https://doi.org/10.1182/blood-2016-02-702852

Published: 2016

Includes: Supplemental data

Journal Articles

A Bortezomib-Based Regimen Offers Excellent Outcomes In Myeloablative HLA-Mismatched and Unrelated Donor Transplantation: Phase II Results

John Koreth, MBBS, DPhil, Haesook T. Kim, PhD, Paulina B. Lange, Bhavjot Bindra, Philippe Armand, MD, PhD, Corey S. Cutler, MD, Vincent T. Ho, MD, Brett Glotzbecker, MD, Jerome Ritz, MD, Bruce R Blazar, MD, Robert J. Soiffer, MD, Joseph H. Antin, MD, Edwin P. Alyea, MD

Blood (2013) 122 (21): 3335.

https://doi.org/10.1182/blood.V122.21.3335.3335

Published: 2013

Journal Articles

Establishment of a karyotypically normal cytotoxic leukemic T-cell line from a T-ALL sample engrafted in SCID mice

A Cesano, R O'Connor, PC Nowell, B Lange, SC Clark, D Santoli

Blood (1993) 81 (10): 2714–2722.

https://doi.org/10.1182/blood.V81.10.2714.2714

Published: 1993

Journal Articles

Monosomy 7 myeloproliferative disease in children with neurofibromatosis, type 1: epidemiology and molecular analysis

KM Shannon, J Watterson, P Johnson, P O'Connell, B Lange, N Shah, P Steinherz, YW Kan, JR Priest

Blood (1992) 79 (5): 1311–1318.

https://doi.org/10.1182/blood.V79.5.1311.1311

Published: 1992

Journal Articles

VH gene rearrangement events can modify the immunoglobulin heavy chain during progression of B-lineage acute lymphoblastic leukemia [see comments]

R Wasserman, M Yamada, Y Ito, LR Finger, BA Reichard, S Shane, B Lange, G Rovera

Blood (1992) 79 (1): 223–228.

https://doi.org/10.1182/blood.V79.1.223.223

Published: 1992

Journal Articles

Homing and progression patterns of childhood acute lymphoblastic leukemias in severe combined immunodeficiency mice

A Cesano, R O'Connor, B Lange, J Finan, G Rovera, D Santoli

Blood (1991) 77 (11): 2463–2474.

https://doi.org/10.1182/blood.V77.11.2463.2463

Published: 1991

Journal Articles

Growth factor requirements of childhood acute T-lymphoblastic leukemia: correlation between presence of chromosomal abnormalities and ability to grow permanently in vitro

R O'Connor, A Cesano, B Lange, J Finan, PC Nowell, SC Clark, SC Raimondi, G Rovera, D Santoli

Blood (1991) 77 (7): 1534–1545.

https://doi.org/10.1182/blood.V77.7.1534.1534

Published: 1991

Journal Articles

Molecular anatomy of a 5q interstitial deletion

L Nagarajan, B Lange, L Cannizzaro, J Finan, PC Nowell, K Huebner

Blood (1990) 75 (1): 82–87.

https://doi.org/10.1182/blood.V75.1.82.82

Published: 1990

Journal Articles

Growth factor requirements of childhood acute leukemia: establishment of GM-CSF-dependent cell lines

B Lange, M Valtieri, D Santoli, D Caracciolo, F Mavilio, I Gemperlein, C Griffin, B Emanuel, J Finan, P Nowell

Blood (1987) 70 (1): 192–199.

https://doi.org/10.1182/blood.V70.1.192.192

Published: 1987

Journal Articles

Childhood Ki-1 lymphoma presenting with skin lesions and peripheral lymphadenopathy

ME Kadin, D Sako, N Berliner, W Franklin, B Woda, M Borowitz, K Ireland, A Schweid, P Herzog, B Lange

Blood (1986) 68 (5): 1042–1049.

https://doi.org/10.1182/blood.V68.5.1042.1042

Published: 1986

Journal Articles

Surface phenotypes of human hemopoietic progenitor cells defined by monoclonal antibodies

D Ferrero, M Gabbianelli, C Peschle, B Lange, G Rovera

Blood (1985) 66 (3): 496–502.

https://doi.org/10.1182/blood.V66.3.496.496

Published: 1985

Journal Articles

Surface phenotype of clonogenic cells in acute myeloid leukemia defined by monoclonal antibodies

B Lange, D Ferrero, S Pessano, A Palumbo, J Faust, P Meo, G Rovera

Blood (1984) 64 (3): 693–700.

https://doi.org/10.1182/blood.V64.3.693.693

Published: 1984

Journal Articles

Subpopulation heterogeneity in human acute myeloid leukemia determined by monoclonal antibodies

S Pessano, A Palumbo, D Ferrero, GL Pagliardi, L Bottero, SK Lai, P Meo, C Carter, H Hubbell, B Lange

Blood (1984) 64 (1): 275–281.

https://doi.org/10.1182/blood.V64.1.275.275

Published: 1984

Journal Articles

A monoclonal antibody that detects expression of transferrin receptor in human erythroid precursor cells

D Lebman, M Trucco, L Bottero, B Lange, S Pessano, G Rovera

Blood (1982) 59 (3): 671–678.

https://doi.org/10.1182/blood.V59.3.671.671

Published: 1982

Journal Articles

Monoclonal antibodies that detect differentiation surface antigens on human myelomonocytic cells

B Perussia, G Trinchieri, D Lebman, J Jankiewicz, B Lange, G Rovera

Blood (1982) 59 (2): 382–392.

https://doi.org/10.1182/blood.V59.2.382.382

Published: 1982

Journal Articles

Differentiation of human leukemias in response to 12-0- tetradecanoylphorbol-13-acetate in vitro

L Pegoraro, J Abrahm, RA Cooper, A Levis, B Lange, P Meo, G Rovera

Blood (1980) 55 (5): 859–862.

https://doi.org/10.1182/blood.V55.5.859.859

Published: 1980

NARROW

Bortezomib-Based Versus Standard of Care Reduced Intensity Conditioning Hematopoietic Stem Cell Transplantation: A Phase II Randomized Controlled Trial

Efficacy, durability, and response predictors of low-dose interleukin-2 therapy for chronic graft-versus-host disease

A Bortezomib-Based Regimen Offers Excellent Outcomes In Myeloablative HLA-Mismatched and Unrelated Donor Transplantation: Phase II Results

Establishment of a karyotypically normal cytotoxic leukemic T-cell line from a T-ALL sample engrafted in SCID mice

Monosomy 7 myeloproliferative disease in children with neurofibromatosis, type 1: epidemiology and molecular analysis

VH gene rearrangement events can modify the immunoglobulin heavy chain during progression of B-lineage acute lymphoblastic leukemia [see comments]

Homing and progression patterns of childhood acute lymphoblastic leukemias in severe combined immunodeficiency mice

Growth factor requirements of childhood acute T-lymphoblastic leukemia: correlation between presence of chromosomal abnormalities and ability to grow permanently in vitro

Molecular anatomy of a 5q interstitial deletion

Growth factor requirements of childhood acute leukemia: establishment of GM-CSF-dependent cell lines

Childhood Ki-1 lymphoma presenting with skin lesions and peripheral lymphadenopathy

Surface phenotypes of human hemopoietic progenitor cells defined by monoclonal antibodies

Surface phenotype of clonogenic cells in acute myeloid leukemia defined by monoclonal antibodies

Subpopulation heterogeneity in human acute myeloid leukemia determined by monoclonal antibodies

A monoclonal antibody that detects expression of transferrin receptor in human erythroid precursor cells

Monoclonal antibodies that detect differentiation surface antigens on human myelomonocytic cells

Differentiation of human leukemias in response to 12-0- tetradecanoylphorbol-13-acetate in vitro

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only